13F filer · CIK 1649339 ↗
Scion Asset Management
You are looking at Q3 2021. See the latest, Q3 2025 →
Reported value
$41.7M
−98% on the quarter before
Positions
6
3 new · 19 sold out
Top 10
100.0%
of the value
Est. gain
+$42,242
on stocks held all quarter
Est. return
+0.1%
on those stocks since Q2 2021
Positions as of Sep 30, 2021, from Scion Asset Management's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2021. Striped tiles are options.
Largest buys
Since Q2 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Lockheed Martin Corp~$10.4MNew · 0.0% → 24.8%+30,000 shares
- Now Inc~$1.1MNew · 0.0% → 2.8%+150,000 shares
- Scynexis Inc~$922,000New · 0.0% → 2.2%+174,030 shares
Largest sells
Since Q2 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- TeslaPUT~$731.0MSold out · 35.1% → 0.0%−1,075,500 underlying
- MetaCALL~$327.3MSold out · 15.7% → 0.0%−941,200 underlying
- Ishares TrPUT~$280.5MSold out · 13.5% → 0.0%−1,943,000 underlying
- AlphabetCALL~$230.3MSold out · 11.1% → 0.0%−91,900 underlying
- Mckesson CorpCALL~$130.5MSold out · 6.3% → 0.0%−682,400 underlying
- Kraft Heinz CoCALL~$58.1MSold out · 2.8% → 0.0%−1,424,800 underlying
- Walmart IncCALL~$53.4MSold out · 2.6% → 0.0%−378,600 underlying
- Cardinal Health IncCALL~$49.0MSold out · 2.4% → 0.0%−857,700 underlying
- Cvs Health CorpCALL~$43.8MSold out · 2.1% → 0.0%−525,300 underlying
- Ark ETF TrPUT~$30.8MSold out · 1.5% → 0.0%−235,500 underlying
Holdings
As of Sep 30, 2021. Changes are in shares against Jun 30, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cvs Health CorpCOM · shares 0% · price +1.7% | 40.7% | $17.0M | +$284,000 | ||||||||
| Lockheed Martin CorpCOM · shares New | 24.8% | $10.4M | — | ||||||||
| Geo Group Inc NewCOM · shares −54% · price +4.9% | 20.7% | $8.7M | +$405,202 | ||||||||
| Corecivic IncCOM · shares −68% · price −15.0% | 8.8% | $3.7M | −$646,959 | ||||||||
| Now IncCOM · shares New | 2.8% | $1.1M | — | ||||||||
| Scynexis IncCOM NEW · shares New | 2.2% | $922,000 | — | ||||||||
| Total · 6 positions | 100% | $41.7M | +$42,242 |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2021 to Q3 2021: 3 stocks held throughout, up $42,242 (+0.1%).
- Geo Group Inc New+$405,202+5%
- Cvs Health Corp+$284,000+2%
- Corecivic Inc−$646,959−15%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2025 | Nov 3, 2025 | $1.38B+139% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $578.3M+190% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $199.2M+157% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $77.4M−40% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $129.8M+147% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $52.5M−49% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $103.5M+9% | SEC ↗ |
| Q4 2023 | Feb 16, 2024 (amended) | $94.6M−4% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $99.0M−94% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.74B+1,524% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $106.9M+130% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $46.5M+13% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $41.3M+1,148% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $3.3M−98% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $201.4M+170% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $74.5M+78% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $41.7M−98% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $2.08B+54% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $1.35B+503% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $224.7M−32% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $330.3M+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $315.3M+267% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $85.9M+4% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $82.3M+38% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $59.6M−36% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $93.6M−5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $98.2M−5% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $103.5M+193% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $35.4M−22% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $45.5M−11% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $51.1M | SEC ↗ |